Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tadao Ohno

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Journal of Biomedical Materials Research. Part A|May 8, 2013
Pore size-dependent immunogenic activity of mesoporous silica-based adjuvants in cancer immunotherapyXiupeng Wang, Xia Li, Atsuo Ito, et al.
Acta Biomaterialia|April 2, 2013
Particle-size-dependent toxicity and immunogenic activity of mesoporous silica-based adjuvants for tumor immunotherapyXiupeng Wang, Xia Li, Atsuo Ito, et al.
European Journal of Immunology|July 14, 2007
Proliferative activation up-regulates expression of CD4 and HIV-1 co-receptors on NK cells and induces their infection with HIV-1Hideki Harada, Yumi Goto, Tadao Ohno, et al.
Experimental Hematology|July 13, 2004
A Wilms tumor cell line, HFWT, can greatly stimulate proliferation of CD56+ human natural killer cells and their novel precursors in blood mononuclear cellsHideki Harada, Satoru Watanabe, Kaoru Saijo, et al.
International Journal of Radiation Oncology, Biology, Physics|July 28, 2004
X-irradiation to human malignant glioma cells enhances the cytotoxicity of autologous killer lymphocytes under specific conditionsEiichi Ishikawa, Koji Tsuboi, Kaoru Saijo, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 25, 2005
Enhancement of T cell proliferative response against autologous cancer cells of a metasatic renal cell carcinoma patient after unexplained regressionKoji Kawai, Kaoru Saijo, Takehiro Oikawa, et al.
Progress in Neurological Surgery|July 11, 2018
Vaccine Therapy of High-Grade GliomasEiichi Ishikawa, Yoshihiro Muragaki, Tetsuya Yamamoto, et al.
World Journal of Surgical Oncology|September 13, 2017
Long-lasting complete response status of advanced stage IV gall bladder cancer and colon cancer after combined treatment including autologous formalin-fixed tumor vaccine: two case reportsYuki Imaoka, Fumito Kuranishi, Tsubasa Miyazaki, et al.
World Journal of Surgical Oncology|August 26, 2011
Long-term survivor of relapsed MFH on the thigh treated with autologous formalin-fixed tumor vaccine (AFTV) combined with limb-sparing surgery and radiotherapyTakeshi Todoroki, Tadashi Kondo, Shinji Sugahara, et al.
Cancer Science|January 15, 2004
Intratumoral injection of IL-2-activated NK cells enhances the antitumor effect of intradermally injected paraformaldehyde-fixed tumor vaccine in a rat intracranial brain tumor modelEiichi Ishikawa, Koji Tsuboi, Shingo Takano, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Journal of Biomedical Materials Research. Part A|May 8, 2013
Pore size-dependent immunogenic activity of mesoporous silica-based adjuvants in cancer immunotherapyXiupeng Wang, Xia Li, Atsuo Ito, et al.
Acta Biomaterialia|April 2, 2013
Particle-size-dependent toxicity and immunogenic activity of mesoporous silica-based adjuvants for tumor immunotherapyXiupeng Wang, Xia Li, Atsuo Ito, et al.
European Journal of Immunology|July 14, 2007
Proliferative activation up-regulates expression of CD4 and HIV-1 co-receptors on NK cells and induces their infection with HIV-1Hideki Harada, Yumi Goto, Tadao Ohno, et al.
Experimental Hematology|July 13, 2004
A Wilms tumor cell line, HFWT, can greatly stimulate proliferation of CD56+ human natural killer cells and their novel precursors in blood mononuclear cellsHideki Harada, Satoru Watanabe, Kaoru Saijo, et al.
International Journal of Radiation Oncology, Biology, Physics|July 28, 2004
X-irradiation to human malignant glioma cells enhances the cytotoxicity of autologous killer lymphocytes under specific conditionsEiichi Ishikawa, Koji Tsuboi, Kaoru Saijo, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 25, 2005
Enhancement of T cell proliferative response against autologous cancer cells of a metasatic renal cell carcinoma patient after unexplained regressionKoji Kawai, Kaoru Saijo, Takehiro Oikawa, et al.
Progress in Neurological Surgery|July 11, 2018
Vaccine Therapy of High-Grade GliomasEiichi Ishikawa, Yoshihiro Muragaki, Tetsuya Yamamoto, et al.
World Journal of Surgical Oncology|September 13, 2017
Long-lasting complete response status of advanced stage IV gall bladder cancer and colon cancer after combined treatment including autologous formalin-fixed tumor vaccine: two case reportsYuki Imaoka, Fumito Kuranishi, Tsubasa Miyazaki, et al.
World Journal of Surgical Oncology|August 26, 2011
Long-term survivor of relapsed MFH on the thigh treated with autologous formalin-fixed tumor vaccine (AFTV) combined with limb-sparing surgery and radiotherapyTakeshi Todoroki, Tadashi Kondo, Shinji Sugahara, et al.
Cancer Science|January 15, 2004
Intratumoral injection of IL-2-activated NK cells enhances the antitumor effect of intradermally injected paraformaldehyde-fixed tumor vaccine in a rat intracranial brain tumor modelEiichi Ishikawa, Koji Tsuboi, Shingo Takano, et al.
Pageof 6